Compounded Semaglutide Online. 2026 Provider Comparison
Compare verified compounded semaglutide online offers and published billing terms. Review the exact medication and commitment before enrolling.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Compare the options first
Full comparison & price terms ↓A short preview in editorial order—not a guarantee of the cheapest total bill. Read the commitment terms before choosing.
$49/mo
Lower listed rate · not necessarily monthly billing
Semaglutide $49/mo or tirzepatide $89/mo with 12-month prepayment; $99/$129 month to month.
From $249/mo
Lower listed rate · not necessarily monthly billing
At the August 26, 2026 price check, Direct Meds listed sublingual semaglutide from $249/month and injections from $297/month. Its public process page says medication, nurse support, shipping, and digital follow-ups are included. A licensed clinician reviews the online intake; confirm treatment, dose, and checkout terms before purchase. Provider-wide published rate; confirm the exact treatment quote.
From $159/mo
Lower listed rate · not necessarily monthly billing
At the October 21, 2026 check, Shed listed compounded semaglutide from $159/month and compounded tirzepatide as low as $239/month, and states that pricing does not increase with dose. Health coaching, follow-ups and shipping are included. Provider-wide published rate; confirm the exact treatment quote.
Compounded semaglutide is dispensed by state-licensed compounding pharmacies and prescribed by licensed clinicians. It is typically less expensive than brand-name Wegovy and is available in injectable, oral-dissolving, and sublingual formats.
Compounded semaglutide contains the same active ingredient as Wegovy and Ozempic but is custom-mixed by a compounding pharmacy. Some formulations include B12 or other adjuncts.
Adults seeking semaglutide weight loss support who prefer the cost flexibility and dose customization that compounded formulations allow.
Pricing typically ranges from $150 to $300 per month. Most platforms use telehealth intake, mailed test kits, and direct pharmacy fulfillment.
Verified Offers for compounded
WellMedr
Compounded GLP-1 care with semaglutide shown at $49/mo or tirzepatide at $89/mo with 12-month prepayment; $99/$129 month to month. Verified affiliate coverage is weight loss only.
Direct Meds
Compounded GLP-1 clinic with transparent pricing and dedicated nurse support.
Shed Rx
GLP-1 clinic offering injections, oral semaglutide, drops, and lozenges plus brand-name Wegovy and Zepbound.
Women-focused telehealth combining compounded GLP-1 weight loss with HRT support.
FuturHealth
GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.
Flexible, medically guided compounded GLP-1 weight loss with transparent monthly pricing.
Refills
Multi-category telehealth platform covering GLP-1, ED, hair loss, and longevity peptides with no membership fees and flat dosage pricing.
Found
GLP-1 platform that pairs medication with one-on-one coaching and a broad off-label formulary.
Strut Health
Broad-catalog telehealth covering hair, skin, weight loss, and sexual health, with free shipping and follow-ups bundled in.
Sprout Health
Compounded GLP-1 plus NAD+ therapy with transparent flat-rate pricing and fast shipping.
Premium GLP-1 clinic with a needle-free sublingual semaglutide tablet option.
Enhance.MD
Provider-led metabolic and NAD+ wellness platform with transparent flat pricing.
Cielo Health
Mission-driven compounded GLP-1 clinic with same-day intake review, transparent pricing, and 10% of proceeds donated to charity.
HealthRx
LegitScript-certified compounded GLP-1 clinic with flat dose pricing — semaglutide from $99/mo and tirzepatide from $149/mo on annual plans, plus ED, hair, and longevity add-ons.
Flat-rate compounded GLP-1 clinic — semaglutide from $99/mo and tirzepatide from $125/mo at every dose, with a 6-month money-back guarantee.
Remote Pharmacy
No-subscription compounded GLP-1 and men's health clinic with same-day approvals, free shipping, and unlimited physician messaging.
Bodybuilding Health+
Provider-guided metabolic, cellular, and sexual performance protocols designed for people who train.
AltRx
Budget-first compounded GLP-1 clinic with a low advertised entry price ($89/mo semaglutide), transparent pricing, and optional brand-name GLP-1 access.
YourEra
Doctor-prescribed compounded GLP-1 injections starting at $99/mo with FSA/HSA eligibility and licensed clinician support.
Pallas Health
Online GLP-1 and NAD+ care with bundled provider support, a $139 compounded-semaglutide first month, and a dedicated NAD+ program.
Compounded GLP-1 telehealth focused on flat plan pricing, with advertised rates tied to annual prepayment.
2026 Price Comparison. Verified Medication Offers
Published provider price terms for offers with a supplied affiliate destination specifically mapped to this medication. Medication, clinician, shipping, and plan-length terms vary; confirm the final checkout total before enrolling.
Recorded price-check dates: 15 June 2026 – 21 October 2026. Per-provider dates below; these are not a guarantee of today's checkout price.
Rates use different billing terms and are not necessarily all-in or month-to-month. Confirm total charges and cancellation terms. Compounded medications are not FDA-approved finished drugs; pharmacy type alone does not establish legality or clinical suitability.
21 providers · Trustpilot scores are customer opinions, not treatment results.
| Provider & billing terms | Lower listed rate | Higher listed rate | Pharmacy | Reviews & price check | Actions |
|---|---|---|---|---|---|
| WellMedrBest Value Rate Semaglutide $49/mo or tirzepatide $89/mo with 12-month prepayment; $99/$129 month to month. | Lower listed rate$49/mo | Higher listed rate$99 – $129/mo | Pharmacy503A | 4.6/5 1,963 reviews 30 August 2026 | Go WellMedrRead full review |
| Direct Meds At the August 26, 2026 price check, Direct Meds listed sublingual semaglutide from $249/month and injections from $297/month. Its public process page says medication, nurse support, shipping, and digital follow-ups are included. A licensed clinician reviews the online intake; confirm treatment, dose, and checkout terms before purchase. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $249/mo | Higher listed rateUp to $297/mo | PharmacyBrand Rx | 4.6/5 14,599 reviews 26 August 2026 | Go Direct MedsRead full review |
| Shed Rx At the October 21, 2026 check, Shed listed compounded semaglutide from $159/month and compounded tirzepatide as low as $239/month, and states that pricing does not increase with dose. Health coaching, follow-ups and shipping are included. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $159/mo | Higher listed rateUp to $239/mo | PharmacyBrand Rx | 4.7/5 956 reviews 21 October 2026 | Go Shed RxRead full review |
| Gala Health Combined GLP-1 + HRT plans bundle medication and provider oversight in a single monthly price. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 4.6/5 3,986 reviews 15 June 2026 | Go Gala HealthRead full review |
| FuturHealth At the October 21, 2026 check, FuturHealth's site listed introductory prices for brand-name medication: Foundayo pill and Wegovy pill as low as $198 for the intro month, and Zepbound KwikPen as low as $395 for the intro month. Ongoing monthly pricing was not published on the page; confirm it at checkout. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $198/mo | Higher listed rateUp to $395/mo | PharmacyBrand Rx | 4.6/5 15,774 reviews 21 October 2026 | Go FuturHealthRead full review |
| Embody Transparent monthly pricing that bundles compounded GLP-1 medication, provider oversight, and shipping into a single fee. No separate membership charge, no dose surcharges, and no long-term contracts. Pricing is disclosed upfront before you complete intake. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $349/mo | PharmacyBrand Rx | 3.8/5 6,332 reviews 15 June 2026 | Go EmbodyRead full review |
| Refills Refills advertises GLP-1 programs from $5/day (approximately $150/mo). No membership or app fees. All dosages are priced the same (no dose-tier price increases). Free shipping. ED medications (sildenafil, tadalafil, Cialis, Viagra), hair loss (finasteride, minoxidil), and longevity peptides (NAD+, sermorelin, methylene blue) are also available. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $150/mo | Higher listed rateUp to $299/mo | PharmacyNot disclosed | 4.0/5 1,425 reviews 24 June 2026 | Go RefillsRead full review |
| Found At the October 21, 2026 check, Found's CORE plan was $129 every 30 days, or $594 for six months (about $99/month); the PLUS self-pay plan was $199/month. Found's terms state GLP-1 medications are not included in any plan fee; Found works with your insurer on coverage, otherwise medication is paid separately. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $129/mo | Higher listed rateUp to $349/mo | PharmacyBrand Rx | 4.0/5 729 reviews 21 October 2026 | Go FoundRead full review |
| Strut Health Strut Health prices each treatment as a flat monthly fee that includes the medication, provider review, and free shipping. There is no separate membership charge. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 3.5/5 777 reviews 15 June 2026 | Go Strut HealthRead full review |
| Sprout Health Flat-rate pricing covers the medication and provider visits in one number. Combined GLP-1 + NAD+ stacks are priced as bundles. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $99/mo | Higher listed rateUp to $299/mo | PharmacyNot disclosed | 4.0/5 158 reviews 15 June 2026 | Go Sprout HealthRead full review |
| Willow Willow bundles physician oversight, medication, free two-day shipping, and unlimited messaging into one premium monthly fee. There is no brand-name medication option and no insurance billing. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $299/mo | Higher listed rateUp to $549/mo | PharmacyBrand Rx | 3.9/5 359 reviews 15 June 2026 | Go WillowRead full review |
| Enhance.MD Enhance.MD uses transparent flat pricing, the monthly subscription includes provider oversight and the chosen medication. NAD+ wafers and injectables are listed at flat in-cart prices. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 4.1/5 159 reviews 15 June 2026 | Go Enhance.MDRead full review |
| Cielo Health Cielo charges from $115/mo for compounded semaglutide and from $180/mo for compounded tirzepatide on a 3-month plan. Single-month rates are $199/mo (semaglutide) and $299/mo (tirzepatide). Physician consult and shipping are included at no extra cost. Every batch is third-party tested. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $115/mo | Higher listed rateUp to $299/mo | PharmacyNot disclosed | 4.3/5 10 reviews 24 June 2026 | Go Cielo HealthRead full review |
| HealthRx Compounded semaglutide from $99/mo (12-month plan) or $133/mo (3-month plan). Compounded tirzepatide from $149/mo (12-month) or $209/mo (3-month). All plans include provider review, dose adjustments, and free overnight shipping. HSA/FSA eligible. 30-day money-back guarantee if provider does not approve. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $99/mo | Higher listed rateUp to $209/mo | Pharmacy503A | 3.4/5 51 reviews 18 July 2026 | Go HealthRxRead full review |
| TrimiLowest Flat Rate Flat rate at every dose. | Lower listed rate$99/mo | Higher listed rate$125/mo | Pharmacy503A | Score unavailable 24 June 2026 | Go TrimiRead full review |
| Remote Pharmacy Remote Pharmacy charges no subscription or membership fee. Compounded tirzepatide starts at $229/mo (starter dose) and $349/mo (maintenance). Compounded semaglutide pricing is comparable. Physician consult and shipping are included at no extra charge. Same-day approvals available for orders placed before 2 pm ET. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $229/mo | Higher listed rateUp to $349/mo | PharmacyNot disclosed | Score unavailable 24 June 2026 | Go Remote PharmacyRead full review |
| Bodybuilding Health+ Bundled monthly pricing covers medication and provider oversight. Performance-stack add-ons are billed per protocol. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $96/mo | Higher listed rateUp to $299/mo | PharmacyNot disclosed | Score unavailable 15 June 2026 | Go Bodybuilding Health+Read full review |
| AltRx AltRx advertises compounded semaglutide from $89/mo (promotional first-month pricing) with standard pricing from $159/mo. Compounded tirzepatide (GLP-1+GIP) starts at $129/mo promotional or $279/mo standard. Brand-name Zepbound and Mounjaro are available from $1,249/mo. No hidden fees, no insurance required. Buy Now Pay Later options available. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $89/mo | Higher listed rateUp to $279/mo | PharmacyBrand Rx | Score unavailable 24 June 2026 | Go AltRxRead full review |
| YourEra YourEra bundles the provider visit, prescription, and compounded GLP-1 medication into a single monthly plan starting at $99. FSA and HSA eligible. No insurance required. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $99/mo | Higher listed rateUp to $299/mo | PharmacyBrand Rx | Score unavailable 15 June 2026 | Go YourEraRead full review |
| Pallas Health Pallas advertises compounded semaglutide at $139 for the first month, then $597 every 12 weeks ($199/mo average), and compounded tirzepatide at $179 for the first month, then $897 every 12 weeks ($299/mo average). Prices include provider care; confirm the renewal charge and medication selection during intake. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $139/mo | Higher listed rateUp to $299/mo | PharmacyBrand Rx | Score unavailable 15 August 2026 | Go Pallas HealthRead full review |
| CoreAge Rx CoreAge Rx’s landing page lists $99/mo and $149/mo GLP-1 plan figures and states that displayed starting prices are based on a 12-month plan paid in full. Confirm the medication, total prepaid amount, fulfillment, and cancellation terms during enrollment; month-to-month pricing was not published on the reviewed page. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $99/mo | Higher listed rateUp to $149/mo | PharmacyNot disclosed | Score unavailable 15 August 2026 | Go CoreAge RxRead full review |
Provider links may earn a commission. Rate sorting compares the displayed numbers, not equivalent treatment plans or total commitments. How we check price terms →
Compounded Semaglutide Legal Status in 2026: What You Need to Know
The FDA declared the semaglutide shortage resolved in February 2025, which ended the shortage-based exemption that had allowed 503A and 503B compounders to produce copies of Wegovy and Ozempic at scale. Under current FDA guidance, 503A pharmacies (patient-specific compounding) can still compound semaglutide if a prescriber documents a clinical rationale for why the patient cannot use the commercially available product. 503B outsourcing facilities (large-scale compounding) are in a more contested position. Some continue to compound semaglutide with added ingredients (B12, L-carnitine, NAD+) under a different regulatory argument.
The practical implication: if you're currently on compounded semaglutide from a telehealth platform, ask your provider which type of pharmacy they use (503A vs. 503B) and whether the pharmacy has received any FDA warning letters. Reputable platforms will be transparent about this. Platforms that cannot or will not answer this question clearly are a red flag.
For most patients, the cleaner path in 2026 is brand-name Wegovy via NovoCare cash-pay at $499/month, the price gap to compounded has narrowed significantly. Compounded semaglutide remains a legitimate option for patients with documented clinical reasons to prefer a customised formulation (e.g., dose flexibility, specific adjunct ingredients, or documented intolerance to the commercial product's excipients).
Injectable vs. Oral vs. Sublingual: Choosing the Right Compounded Format
Compounded semaglutide is available in three main formats: subcutaneous injectable (the same route as Wegovy), oral-dissolving tablets (ODT), and sublingual drops. The injectable format has the most clinical evidence behind it. It's the same route as the brand-name product, so efficacy is most directly comparable to the STEP trial data. Most platforms default to injectable.
Oral compounded semaglutide is a different proposition from the FDA-approved oral semaglutide pill (Rybelsus/wegovy-pill). Compounded oral semaglutide typically uses a higher dose to compensate for lower bioavailability and is not bioequivalent to the injectable. The FDA has raised concerns about the bioavailability claims made by some compounders for oral formats. If a platform is recommending oral compounded semaglutide, ask for the specific dose and bioavailability data they're using.
Sublingual drops are the least studied format and the most variable in quality. They're sometimes marketed as 'faster-acting' or 'more convenient,' but there is no published clinical data on sublingual semaglutide bioavailability from compounded formulations. Treat sublingual compounded semaglutide with more skepticism than injectable or oral formats until more data is available.
What the Studies Actually Show
Compounded semaglutide contains the same active ingredient as Wegovy and Ozempic. There are no randomized trials of compounded formulations themselves; efficacy is inferred from the trials of the underlying API and from the FDA prescribing information for the brand-name product.
| Endpoint | Finding |
|---|---|
| Mean weight loss (STEP 1, 68 weeks, 2.4 mg)1 | −14.9% body weight vs −2.4% placebo in adults with overweight/obesity without diabetes |
| Cardiovascular outcomes (SELECT, ~40 months)2 | 20% relative risk reduction in major adverse cardiovascular events (MACE) in adults with established CV disease and overweight/obesity |
| GI side effects (FDA prescribing information)3 | Nausea ≥10%, diarrhea ≥10%, vomiting ≥10%, constipation ≥10%; most cases mild–moderate and dose-dependent |
| Boxed warning3 | Risk of thyroid C-cell tumors observed in rodent studies; contraindicated in personal/family history of MTC or MEN 2 |
| A1C reduction (T2D, SUSTAIN program)4 | ≈1.4–1.8% A1C reduction at 1.0 mg weekly across SUSTAIN-2 through SUSTAIN-7 head-to-head trials |
| Compounded semaglutide — evidence basis5 | Active ingredient is identical to Wegovy/Ozempic; efficacy is inferred from the active ingredient. The FDA does not formally approve compounded products; quality depends on the 503A/503B compounding pharmacy Following the FDA's 2024 ruling that ended the official tirzepatide and semaglutide shortages, compounded GLP-1s are dispensed under the personalisation exception, which requires a documented clinical justification (custom dose, B12 addition, or documented intolerance to an inactive ingredient). |
Frequently Asked Questions
Is compounded semaglutide legal?
Yes, when prescribed by a licensed clinician and dispensed by a state-licensed compounding pharmacy. The FDA periodically updates guidance, so always verify the pharmacy's current licensure status.
- STEP 1 — NEJM 2021 · Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021;384:989–1002.
- SELECT — NEJM 2023 · Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med 2023;389:2221–2232.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.